Stifel Financial Corp Crispr Therapeutics Ag Transaction History

Stifel Financial Corp

$93.7 Billion
Q4 2024

A detailed history of Stifel Financial Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Stifel Financial Corp holds 43,128 shares of CRSP stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,128

Previous 40,237 7.18%

Holding current value

$1.85 Million

Previous $1.89 Million 10.21%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$38.65 - $55.15 $111,737 - $159,438	2,891 Added 7.18%	43,128 $1.7 Million
Q3 2024 Nov 14, 2024	SELL	$44.62 - $62.75 $454,008 - $638,481	-10,175 Reduced 20.18%	40,237 $1.89 Million
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $461,553 - $614,983	-9,020 Reduced 15.18%	50,412 $2.72 Million
Q1 2024 May 13, 2024	BUY	$60.67 - $89.12 $277,868 - $408,169	4,580 Added 8.35%	59,432 $4.05 Million
Q4 2023 Feb 12, 2024	BUY	$38.62 - $72.18 $1.08 Million - $2.02 Million	27,973 Added 104.07%	54,852 $3.43 Million
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $89,962 - $116,938	-1,982 Reduced 6.87%	26,879 $1.22 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $29,646 - $46,219	-682 Reduced 2.31%	28,861 $1.62 Million
Q1 2023 May 12, 2023	SELL	$41.0 - $56.12 $17,220 - $23,570	-420 Reduced 1.4%	29,543 $1.34 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $31,234 - $52,338	797 Added 2.73%	29,963 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $370,877 - $508,544	6,070 Added 26.28%	29,166 $1.91 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $455,168 - $777,356	-10,529 Reduced 31.31%	23,096 $1.4 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $225,206 - $335,502	4,234 Added 14.41%	33,625 $2.11 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $422,712 - $671,189	-6,031 Reduced 17.03%	29,391 $2.23 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.43 Million - $2.04 Million	13,004 Added 58.01%	35,422 $3.97 Million
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $7,260 - $11,656	-72 Reduced 0.32%	22,418 $3.63 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $629,886 - $1.19 Million	5,689 Added 33.86%	22,490 $2.74 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $331,905 - $721,676	4,166 Added 32.97%	16,801 $2.57 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $58,247 - $74,674	742 Added 6.24%	12,635 $1.06 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $14,938 - $29,507	-388 Reduced 3.16%	11,893 $874,000
Q1 2020 May 14, 2020	BUY	$33.68 - $62.53 $24,215 - $44,959	719 Added 6.22%	12,281 $522,000
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $64,813 - $129,220	1,767 Added 18.04%	11,562 $705,000
Q3 2019 Nov 13, 2019	BUY	$40.99 - $52.56 $61,116 - $78,366	1,491 Added 17.96%	9,795 $400,000
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $294,376 - $400,252	8,304 New	8,304 $399,000

Others Institutions Holding CRSP

# of Institutions

488

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.34B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Crispr Therapeutics Ag Transaction History